Added: Aida Tineo - Date: 02.12.2021 23:42 - Views: 14172 - Clicks: 9028
Study record managers: refer to the Data Element Definitions if submitting registration or information. Talk with your doctor and family members or friends about deciding to a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies. Try the modernized ClinicalTrials. Learn more about the modernization effort. Hide glossary Glossary Study record managers: refer to the Data Element Definitions if submitting registration or information.
Search for terms. Save this study. Warning You have reached the maximum of saved studies Listing a study does not mean it has been evaluated by the U. Federal Government. Read our disclaimer for details. First Posted : May 1, Last Update Posted : March 3, Study Description. To answer the question of overall benefit: risk of celecoxib when compared to two most commonly prescribe traditional non-selective nonsteroidal anti-inflammatory drugs NSAIDs in the treatment of arthritis pain.
For this purpose, patients with osteoarthritis or rheumatoid arthritis with or at risk of developing cardiovascular disease will be recruited. The cardiovascular, gastrointestinal and renal safety and symptomatic benefit in each treatment group will be assessed accordingly.
MedlinePlus related topics: Arthritis Rheumatoid Arthritis.
FDA Resources. Arms and Interventions. Outcome Measures. CSGIE include: Gastroduodenal GD hemorrhage, Gastric outlet obstruction, Gastroduodenal, small bowel or large bowel perforation, Large bowel hemorrhage, Small bowel hemorrhage, Acute GI hemorrhage of unknown origin, including pd small bowel hemorrhage, Symptomatic gastric or duodenal ulcer. VAS question "How much pain do you have" was graded on a scale from 0 to with 0 indicating "No pain" and indicating "Worst possible pain".
Eligibility Criteria. Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Inclusion Criteria: Subjects with osteoarthritis or rheumatoid Arthritis with or at risk of developing cardiovascular disease and who require and eligible for chronic, daily therapy with an NSAID to control arthritis and symptoms.
Contacts and Locations. Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.
Watkins, M. Robert L. Arvind J. Kades, MD, Inc. Adetola, M. McDermott, Jr. Ricardo A. Bedoya, M. Juvenal E. Feinberg, D. Duluth, Minnesota, United States, St. Luke's Hospital Association of Duluth, Inc. Slabic, M. Joseph T. McDonald, M. Long, D. Robert C. Milton F. Brian N. Jonathan D. Robert G. Azim M. Swaran K. Mexico, D. V Mexico, D. Pfizer's Upjohn has merged with Mylan to form Viatris Inc. More Information. Additional Information: To obtain contact information for a study center near you. Clinicoecon Outcomes Res. Clin Trials.
Epub Jul 9. Arthritis Rheumatol. Epub Jun J Am Coll Cardiol. Eur Heart J. N Engl J Med. Epub Nov National Library of Medicine U. National Institutes of Health U. Department of Health and Human Services. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Arthritis, Rheumatoid. Drug: celecoxib Drug: Ibuprofen Drug: Naproxen. Phase 4. Study Type :. Interventional Clinical Trial.
Actual Enrollment :.
Triple Participant, Care Provider, Investigator. Actual Study Start Date :.
Actual Primary Completion Date :. Actual Study Completion Date :. Experimental: celecoxib subject receives celecoxib and dummy placebo ibuprofen and naproxen. Drug: celecoxib to mg twice daily, taken by mouth. Active Comparator: ibuprofen subject receives ibuprofen and dummy placebo celecoxib and naproxen. Drug: Ibuprofen ibuprofen mg to mg three times daily, taken by mouth. Active Comparator: naproxen subject receives naproxen and dummy placebo celecoxib and ibuprofen.
Drug: Naproxen naproxen mg to mg twice daily, taken by mouth.Adult seeking nsa ID Coeur d alene 83814
email: [email protected] - phone:(620) 977-4618 x 4635
July Coeur d'Alene Living Local